INVEST WITH ONE 
OF AUSTRALIA’S MOST INNOVATIVE COMPANIES.

Fixed rate returns of 9% p.a. over 1 year or 11% p.a. over 2 years.*

ENQUIRE NOW

INVEST WITH ONE OF AFR'S TOP INNOVATIVE COMPANIES 
OF 2019.

Fixed rate returns of
9% p.a. over 1 year or 
11% p.a. over 2 years.*

AS FEATURED IN

iQnovate Ltd manages bioscience intellectual property assets from some of the most respected universities and researchers around the world, providing research and development capabilities and detailed strategies to take these assets from the discovery stage to become commercially successful healthcare innovations.

As a private investor in an iQnovate Ltd corporate note, you will help create the medicines of tomorrow while receiving a fixed income return over your choice of one or two years.

SHORT MATURITY
TERMS

Choose the maturity term that suits you, with 9% p.a. over 1 year or 11% p.a. over 2 years.

FIXED TERM
DEPOSIT RATES

Receive a fixed annual rate, even in an uncertain or fluctuating financial market.

HIGHER YIELDING
INTEREST

Obtain greater returns than with cash interest rates or conventional investments.

LOW MINIMUM
AND LOW RISK

Invest with a globally recognised company for as little as A$50,000. 

Investor benefits

iQnovate Ltd is a publicly listed organisation trading on the National Stock Exchange of Australia (IQN) since 2011 and cross listed on the OTCQB in New York (IQNDY).

Why partner with us?

01

Globally recognised by financial and healthcare media. 

AWARD WINNING

02

PROVEN SUCCESS

Four direct listings on Australian exchanges and multiple listings in the pipeline.

03

GLOBAL EXPERTISE

A team of 200+ passionate people comprised of investment bankers, scientists, physicians, and commercial experts.

Shanghai

New York

Sydney

04

WORLD CLASS INSTITUTIONS 

Bioscience assets developed in collaboration with world class institutions.

Do I qualify as a wholesale investor? 

The wholesale corporate note market is typically restricted to large financial institutions, leaving little opportunity for private investors. iQnovate Ltd is offering access to this market to wholesale investors with a minimum $50,000 investment, providing a unique opportunity for attractive investment returns.

To qualify you will need to acquire a certificate from a qualified accountant confirming:

  • You have net assets of $2.5 million, and/or
  • That your gross income for the past two financial years has been at least $250,000 per year. 

A fixed income return of 9% over one year.*

A fixed income return of 11% over two years.*

Interest is calculated daily and paid quarterly to your nominated account.

Our Investor Engagement Team will be in touch within 24 hours to discuss your eligibility and provide a detailed information pack. 

We respect your privacy and will never share your details with anyone. Check our Privacy Policy.

ENQUIRE NOW

Level 9, 85 Castlereagh Street Sydney NSW 2000 Australia

© Copyright 2019 The iQ Group Global. All Rights Reserved. Privacy Policy

Investor benefits

FIXED TERM
DEPOSIT RATES

Receive a fixed annual rate, even in an uncertain or fluctuating financial market.

SHORT MATURITY
TERMS

Choose the maturity term that suits you, with 9%  p.a. over 1 year or 11% p.a. over 2 years.

HIGHER YIELDING
INTEREST

Obtain greater returns than with cash interest rates or conventional investments.

LOW MINIMUM
AND LOW RISK

Invest with a globally recognised company for as little as A$50,000.

Why partner with us?

01

AWARD WINNING

Globally recognised by financial and healthcare media.

02

PROVEN SUCCESS

Four direct listings on Australian exchanges and multiple listings in the pipeline.

03

GLOBAL PRESENCE

A team of 200+ passionate people comprised of investment bankers, scientists, physicians, and commercial experts.

Shanghai

New York

Sydney

04

WORLD CLASS INSTITUTIONS

Bioscience assets developed in collaboration with world-class institutions.

investor.relations@theIQgroupglobal.com

*for wholesale investors only.

*for wholesale investors only.

IMPORTANT INFORMATION

The information contained on this website and in the materials relating to the offer of convertible notes (Offer) (Information Materials) has been prepared by iQnovate Ltd ACN 149 731 644 (Company). This Information Materials have been prepared for a limited purpose and are not intended for general circulation or publication.

The Offer

The Offer is only available by submitting your details using the 'Request a call' function.

To participate in the Offer you must represent and warrant that:

  • if you are in Australia, you are a person to whom an offer of securities may be made without a disclosure document (as defined in the Corporations Act 2001 (Cth) (Corporations Act) on the basis that you are a sophisticated or professional investor within the meaning set out in section 708(8) of the Corporations Act, or a wholesale client within the meaning set out in section 761G of the Corporations Act and you have provided the Company with a valid accountant's certificate certifying that you have a gross income of AUD$250,000 or more per annum in each of the previous two years (before the certificate was issued) or have net assets of at least AUD$2.5 million;
  • you are not in the United States or acting for the account or benefit of someone in the United States; and
  • if you are outside Australia, you are a person to whom an offer and issue of securities may be made without registration, lodgement or approval of a formal disclosure document or other filing in accordance with the laws of the relevant foreign jurisdiction (except to the extent that Company, in its absolute discretion, is willing to do so).

If you are not such a person, you are not able to participate in the Offer and should not read the Information Materials.

Not an offer or financial product advice
The Information Materials are being provided for information purposes only and are not a prospectus, product disclosure statement or other disclosure document for the purposes of the Corporations Act or other offer document under Australian law or the law of any other jurisdiction.  The Information Materials are not and should not be considered, and do not contain or purport to contain, an offer, invitation, solicitation, advertisement or recommendation with respect to the purchase or sale of any securities in the Company (Securities) (notwithstanding the references to 'the Offer' and the 'Offer terms' in the Information Materials) nor does it constitute financial product or investment advice nor take into account your investment objectives, taxation situation, financial situation or needs. Neither the Information Materials nor anything contained in it shall form the basis of any contract or commitment and it is not intended to induce or solicit any person to engage in, or refrain from engaging in, any transaction. Your participation in the Offer will be governed by the terms of the [Corporate Note Deed][ iQNovate corporate note issue 2019] which can be obtained as part of the application process.].

The Information Materials do not constitute an offer to sell, or a solicitation of an offer to buy, any Securities in the United States or to any 'US persons' (as defined in Regulation S under the US Securities Act of 1933, as amended (Securities Act) (U.S. Persons). No Securities have been, nor will be, registered under the Securities Act or any securities laws of any state or other jurisdiction of the United States and may not be offered, sold or otherwise transferred except in a transaction exempt from, or not subject to, the registration requirements of the Securities Act and any other applicable securities laws.

An investor must not act on the basis of any matter contained in this Information Materials but must make its own assessment of the Company and the Offer and conduct its own investigation and analysis.

Past performance
The operating and historical financial information given in the Information Materials is given for illustrative purposes only and should not be relied upon as (and is not) an indication of the Company's views as to its future performance or condition. You should note that past performance of the Company cannot be relied upon as an indicator of (and provides no guidance as to) future performance.

No liability
The Company has prepared these Information Materials based on information available to it at the time of preparation, from sources believed to be reliable and subject to the qualifications in these Information Materials. To the maximum extent permitted by law, each of the Company and its affiliates, related bodies corporate (as that term is defined in the Corporations Act), shareholders, directors, employees, officers, representatives, agents, partners, consultants and advisers (each a Limited Party and together, the Limited Parties) accept no responsibility or liability for the contents of the Information Materials and make no recommendation or warranties. No representation or warranty, express or implied, is made as to the fairness, accuracy, adequacy, validity, correctness or completeness of the information, opinions and conclusions contained in the Information Materials. To the maximum extent permitted by law, none of the Limited Parties accept any responsibility or liability including, without limitation, any liability arising from fault or negligence on the part of any person, for any loss whatsoever arising from the use of the information in the Information Materials or their contents or otherwise arising in connection with them.

Acknowledgment and representation and warranty
By receiving or accessing the Information Materials you acknowledge and agree that you understand the contents of this notice and that you agree to abide by its terms and conditions.